- Download
Xolair® terugbetaling: heropstart
DownloadPyrexia Management Leaflet (French)
Ressources Patients
NovAssist ® - Patient Support Program Cosentyx ® NovAssist is a support program for your patients treated with Cosentyx ® . This program will help them, according to their needs and through...
Twitter Linkedin Facebook Pinterest Google plusMechanism of Action
Kesimpta ® is a targeted and precisely delivered B-cell therapy 1,3B-cells play a central role in the pathogenesis of MS 2
KESIMPTA ® (ofatumumab) is a fully human anti...
Twitter Linkedin Facebook Pinterest Google plusSafety Profile
A demonstrated safety and tolerability profile 2
Rate of infections between KESIMPTA ® and teriflunomide was comparable 1
1. Kesimpta...
Twitter Linkedin Facebook Pinterest Google plusReimbursement / E-health
Kesimpta ® is reimbursed in Belgium for adult patients with clinically proven relapsing multiple sclerosis (RMS) who meet the following criteria* :
The patient has highly active relapsing multiple sclerosis or
The patient...
Twitter Linkedin Facebook Pinterest Google plusEfficacy
Kesimpta provides significant reduction in relapses of up to nearly 60% vs teriflunomide in RMS patients 1,2
Kesimpta shows a profound reduction...
Twitter Linkedin Facebook Pinterest Google plusIndication
Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with active disease defined by clinical or imaging features 1
Both newly diagnosed patients and patients switching from...
Twitter Linkedin Facebook Pinterest Google plusAdministration & Dosing
KESIMPTA ® offers the flexibility of a self-administered B-cell therapy 1
After initial dosing, KESIMPTA ® 20 mg is administered (sc) once monthly 1 ...
Twitter Linkedin Facebook Pinterest Google plus